Detailed Information
Cited 20 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A randomized, double-blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection with or without adjuvant chemotherapy in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC): RADIANT results.
- Authors
- Kelly, Karen; Altorki, Nasser K.; Eberhardt, Wilfried Ernst Erich; O'Brien, Mary E. R.; Spigel, David R.; Crino, Lucio; Tsai, Chun-Ming; Kim, Joo-Hang; Cho, Eun Kyung; Szczesna, Aleksandra; Burghuber, Otto; Hoffman, Philip C.; Keshavjee, Shaf; Orlov, Sergey; Serwatowski, Piotr; Wang, Jiuzhou; Foley, Margaret A.; Horan, Julie D.; Park, Jung Wook; Shepherd, Frances A.
- Issue Date
- 20-May-2014
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.32, no.15
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 32
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Cho, Eun Kyung
- College of Medicine (Department of Medicine)